BA
The Boeing Company
BA has a slight edge over KSCP overall, supported by lower modeled downside and stronger fundamentals.
KSCP
Knightscope, Inc.
KSCP offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
KSCP Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
KSCP's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
KSCP PE Valuation
KSCP has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
KSCP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect KSCP's losses to shrink, with revenue growing.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the stronger earnings trend. Trailing diluted EPS is down 30% for BA versus KSCP down 120%.
KSCP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$14.58 | +$12.92 |
| Q2 2024 | -$16.50 | +$12.50 |
| Q1 2024 | -$18.00 | +$6.00 |
| Q4 2023 | -$17.00 | +$19.00 |
| Q3 2021 | -$163.00 | -$81.50 |
| Q2 2021 | -$161.50 | -$89.50 |
| Q1 2021 | -$100.50 | -$34.00 |
| Q4 2020 | -$96.00 | -$35.00 |
KSCP is still losing money, but far less than before: $2.87 per share over the past year, against $163.00 at its worst in late 2021.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA has the edge over KSCP on profitability, with a higher operating margin.
KSCP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.7M | +177% |
| Q2 2026 | $9M | +228% |
| Q1 2026 | $6M | +106% |
| Q4 2025 | $2.5M | -9.8% |
| Q3 2025 | $3.1M | +24% |
| Q2 2025 | $2.7M | -14% |
| Q1 2025 | $2.9M | +29% |
| Q4 2024 | $2.8M | -6.6% |
KSCP's revenue has picked up after two years of holding roughly level: $9M last quarter, up 177% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -133% | +171 points |
| Q2 2026 | -145% | +83 points |
| Q1 2026 | -172% | +62 points |
| Q4 2025 | -445% | -200 points |
| Q3 2025 | -304% | +1.7 points |
| Q2 2025 | -228% | -17 points |
| Q1 2025 | -234% | +133 points |
| Q4 2024 | -245% | -1.6 points |
KSCP's operating margin was −133% last quarter, up 170 points from the same quarter a year ago, near the top of its range since 2019.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over KSCP on cash generation, producing positive trailing cash flow while its opponent burns cash.
KSCP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.1M | -$3M |
| Q1 2026 | -$11.7M | -$5.3M |
| Q4 2025 | -$10.9M | -$5.7M |
| Q3 2025 | -$8.1M | -$3.4M |
| Q4 2024 | -$5.1M | +$893K |
| Q3 2024 | -$4.7M | +$2.2M |
| Q4 2023 | -$6M | -$292K |
| Q3 2023 | -$6.9M | -$2.2M |
KSCP has burned cash in almost every quarter: −$45M over the past year, against −$24M the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
KSCP Net Leverage
KSCP's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
KSCP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 20.1 | Oversold |
| Stochastic | 3.4 | Oversold |
KSCP's weekly RSI is 20 (oversold) and its Stochastic is 3 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
KSCP PE vs Industrials Sector
KSCP has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
KSCP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.59 | 25% below |
| 20 week MA | $1.15 | 62% below |
| 50 week MA | $2.58 | 83% below |
| 100 week MA | $4.63 | 90% below |
| 200 week MA | $17.9 | 98% below |
KSCP is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over KSCP on returns for 2026, with the stronger performance.
KSCP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $814.5 | $85.5 | -90% |
| 2023 | $85.5 | $30.0 | -65% |
| 2024 | $30.0 | $14.0 | -54% |
| 2025 | $14.0 | $3.96 | -72% |
| 2026 YTD | $3.96 | $0.44 | -89% |
KSCP has finished every year since 2022 lower, and it's down 89% so far in 2026.